Related references
Note: Only part of the references are listed.Organic Cation Transporters in Human Physiology, Pharmacology, and Toxicology
Sophia L. Samodelov et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2020)
Role of Imaging in Esophageal Cancer Management in 2020: Update for Radiologists
Vetri Sudar Jayaprakasam et al.
AMERICAN JOURNAL OF ROENTGENOLOGY (2020)
Effects of Single Nucleotide Polymorphism Ala270Ser (rs316019) on the Function and Regulation of hOCT2
Dominik Frenzel et al.
BIOMOLECULES (2019)
L-Carnitine-Mediated Tumor Cell Protection and Poor Patient Survival Associated with OCTN2 Overexpression in Glioblastoma Multiforme
Matthias A. Fink et al.
CLINICAL CANCER RESEARCH (2019)
Fluorocholine Transport Mediated by the Organic Cation Transporter 2 (OCT2, SLC22A2): Implication for Imaging of Kidney Tumors
Michele Visentin et al.
DRUG METABOLISM AND DISPOSITION (2018)
Effectiveness of neoadjuvant chemotherapy with etoposide and cisplatin followed by surgery for esophageal neuroendocrine carcinoma: a case report
Alamo Yamamoto et al.
JOURNAL OF THORACIC DISEASE (2018)
Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries
Freddie Bray et al.
CA-A CANCER JOURNAL FOR CLINICIANS (2018)
Low expression level of ASK1-interacting protein-1 correlated with tumor angiogenesis and poor survival in patients with esophageal squamous cell cancer
Dongfeng Sun et al.
ONCOTARGETS AND THERAPY (2018)
Impact of Organic Cation Transporters (OCT-SLC22A) on Differential Diagnosis of Intrahepatic Lesions
Michele Visentin et al.
DRUG METABOLISM AND DISPOSITION (2017)
Cancer of the Esophagus and Esophagogastric Junction: An Eighth Edition Staging Primer
Thomas W. Rice et al.
JOURNAL OF THORACIC ONCOLOGY (2017)
Colistin is substrate of the carnitine/organic cation transporter 2 (OCTN2, SLC22A5)
Michele Visentin et al.
DRUG METABOLISM AND DISPOSITION (2017)
OCTN1 Is a High-Affinity Carrier of Nucleoside Analogues
Christina D. Drenberg et al.
CANCER RESEARCH (2017)
Epigenetic activation of the drug transporter OCT2 sensitizes renal cell carcinoma to oxaliplatin
Yanqing Liu et al.
SCIENCE TRANSLATIONAL MEDICINE (2016)
Comparative effectiveness and safety between oxaliplatin-based and cisplatin-based therapy in advanced gastric cancer: A meta-analysis of randomized controlled trials
Jun Huang et al.
ONCOTARGET (2016)
Methylomes of renal cell lines and tumors or metastases differ significantly with impact on pharmacogenes
Stefan Winter et al.
SCIENTIFIC REPORTS (2016)
Cancer statistics for Hispanics/Latinos, 2015
Rebecca L. Siegel et al.
CA-A CANCER JOURNAL FOR CLINICIANS (2015)
Prognostic Classification of Histopathologic Response to Neoadjuvant Therapy in Esophageal Adenocarcinoma
Arnulf H. Hoelscher et al.
ANNALS OF SURGERY (2014)
Luteolin potentiates the sensitivity of colorectal cancer cell lines to oxaliplatin through the PPARγ/OCTN2 pathway
Qiang Qu et al.
ANTI-CANCER DRUGS (2014)
The Role of Organic Anion Transporters in Diagnosing Liver Diseases by Magnetic Resonance Imaging
Catherine M. Pastor et al.
DRUG METABOLISM AND DISPOSITION (2014)
The SLC22 family with transporters of organic cations, anions and zwitterions
Hermann Koepsell
MOLECULAR ASPECTS OF MEDICINE (2013)
Oxaliplatin-induced neurotoxicity is dependent on the organic cation transporter OCT2
Jason A. Sprowl et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2013)
Inhibition of OCTN2-Mediated Transport of Carnitine by Etoposide
Chaoxin Hu et al.
MOLECULAR CANCER THERAPEUTICS (2012)
Epidemiologic differences in esophageal cancer between Asian and Western populations
Han-Ze Zhang et al.
CHINESE JOURNAL OF CANCER (2012)
Drug transporters of platinum-based anticancer agents and their clinical significance
Herman Burger et al.
DRUG RESISTANCE UPDATES (2011)
Oxaliplatin Transport Mediated by Organic Cation/Carnitine Transporters OCTN1 and OCTN2 in Overexpressing Human Embryonic Kidney 293 Cells and Rat Dorsal Root Ganglion Neurons
Nancy N. Jong et al.
JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS (2011)
Organic Cation Transporter 2 Mediates Cisplatin-Induced Oto- and Nephrotoxicity and Is a Target for Protective Interventions
Giuliano Ciarimboli et al.
AMERICAN JOURNAL OF PATHOLOGY (2010)
Colon OCTN2 Gene Expression Is Up-regulated by Peroxisome Proliferator-activated Receptor γ in Humans and Mice and Contributes to Local and Systemic Carnitine Homeostasis
Giuseppe D'Argenio et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2010)
Biologic Correlation of 2-[18F]-Fluoro-2-Deoxy-D-Glucose Uptake on Positron Emission Tomography in Thymic Epithelial Tumors
Kyoichi Kaira et al.
JOURNAL OF CLINICAL ONCOLOGY (2010)
Hepatic uptake of γ-butyrobetaine, a precursor of carnitine biosynthesis, in rats
Masaharu Fujita et al.
AMERICAN JOURNAL OF PHYSIOLOGY-GASTROINTESTINAL AND LIVER PHYSIOLOGY (2009)
Contribution of Organic Cation Transporter 2 (OCT2) to Cisplatin-Induced Nephrotoxicity
K. K. Filipski et al.
CLINICAL PHARMACOLOGY & THERAPEUTICS (2009)
The Relationship between the Glucose Transporter Type 1 Expression and F-18-Fluorodeoxyglucose Uptake in Esophageal Squamous Cell Carcinoma
Yukiharu Hiyoshi et al.
ONCOLOGY (2009)
PPARα mediates transcriptional upregulation of novel organic cation transporters-2 and -3 and enzymes involved in hepatic carnitine synthesis
Alexander Koch et al.
EXPERIMENTAL BIOLOGY AND MEDICINE (2008)
Correlation between FDG uptake and glucose transporter type 1 expression in neuroendocrine tumors of the lung
Yoo Sung Song et al.
LUNG CANCER (2008)
Treatment with pharmacological peroxisome proliferator-activated receptor α agonist clofibrate causes upregulation of organic cation transporter 2 in liver and small intestine of rats
Robert Ringseis et al.
PHARMACOLOGICAL RESEARCH (2007)
Cisplatin and oxaliplatin, but not carboplatin and nedaplatin, are substrates for human organic cation transporters (SLC22A1-3 and multidrug and toxin extrusion family)
Atsushi Yonezawa et al.
JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS (2006)
Antioxidant and antiradical activities of L-carnitine
I Gülçin
LIFE SCIENCES (2006)
Organic cation/carnitine transporter OCTN2 (Slc22a5) is responsible for carnitine transport across apical membranes of small intestinal epithelial cells in mouse
Yukio Kato et al.
MOLECULAR PHARMACOLOGY (2006)
Predictive and prognostic molecular markers in outcome of esophageal cancer
D. Vallboehmer et al.
DISEASES OF THE ESOPHAGUS (2006)
Chemoradiation with and without surgery in patients with locally advanced squamous cell carcinoma of the esophagus
M Stahl et al.
JOURNAL OF CLINICAL ONCOLOGY (2005)
Na+-coupled transport of L-carnitine via high-affinity carnitine transporter OCTN2 and its subcellular localization in kidney
I Tamai et al.
BIOCHIMICA ET BIOPHYSICA ACTA-BIOMEMBRANES (2001)
Utility of positron emission tomography for the staging of patients with potentially operable esophageal carcinoma
P Flamen et al.
JOURNAL OF CLINICAL ONCOLOGY (2000)
Share Paper
